Parkinson's didn't stop for coronavirus, and neither did we. Here are the three things we’re most proud of this year, and how you can get involved in 2021.
Parkinson’s UK joins forces with other neurological charities to raise our concerns about the impact of the pandemic on accessing rehabilitation services, like physio, speech and language and occupational therapy for our community.
Scientists in the UK have developed a tomato plant that produces high levels of levodopa. This research may help more people access this important Parkinson's medication.
Our 2020 volunteer award winners have been announced
Our recent survey has found that nearly three quarters (74%) of people on Parkinson's medication experience 'wearing off', when symptoms including pain, stiffness and tremors become worse between doses.
Update on availability of Ropinirole (Spiroco) 4mg XL - 28 tablets
Our advice on how to manage Parkinson's and deal with cold weather and seasonal illnesses this winter.
A summary of what the latest Spending Review means for our community
Parkinson’s UK is joining forces with US charity The Michael J. Fox Foundation and biopharma company Neurolixis to fund a £1.5m clinical trial of an exciting new drug to combat dyskinesia in people with Parkinson’s.
Parkinson's UK is launching a grant scheme with Sport Parkinson’s CIC to revolutionise the sport and exercise world for people living with Parkinson's.